Open House Details

  • 2:00 - 3:00 PM EDT

  • September 28th, 2022

  • Live/Online

This Open House is intended for those interested in learning more about the Postgraduate Certificate in Ketamine-Assisted Psychotherapy (KAP). The Certificate in Ketamine-Assisted Therapy is designed to teach clinicians to engage in Ketamine-Assisted Psychotherapy in clinical settings. The Certificate is not a license or authorization to practice therapy in itself, but a course of study covering key elements and experiences, providing exposure to mentors and leaders in the field, and introducing participants to a peer group for ongoing professional support and development.

We welcome all who are interested in the certificate program to attend and meet our staff for a brief overview of the program followed by a Q&A period. All registrants who complete this program will receive an application fee waiver code, $100 Value.

Find out more about this certificate program by clicking here.

Instructor(s)

Ketamine-Assisted Psychotherapy Certificate Program Director

Donna Sorgen, LMHC, LPC

Donna Sorgen, LMHC,LPC (she/her) is a psychotherapist with over 25 years experience working with adults, children, adolescents, couples and groups. She is the Director/Owner of the Woodstock Therapy Center, a collective of practitioners providing a variety of services to the community including Ketamine Assistant Psychotherapy (KAP), psychiatric services , psychotherapy and holistic modalities. Donna has spent her career working with diverse clients in multiple settings. Her current private practice includes KAP, Psychotherapy and Psychedelic integration therapy. Donna has completed training in MDMA-Assisted Psychotherapy for PTSD through the Multidisciplinary Association for Psychedelic Studies(MAPS). She was a sushi chef, caterer and enjoys the outdoors and gardening.

Lead Trainer

Elizabeth Nielson, PhD

Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment PTSD, and psilocybin-assisted treatment of treatment resistant depression. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her program of research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.